Instrumented Strength Assessment in Typically Developing Children and Children with a Neural or Neuromuscular Disorder: A Reliability, Validity and Responsiveness Study

Overview

Journal Front Physiol

Date 2022 Nov 7

PMID 36338500

Authors

Ineke Verreydt

Ines Vandekerckhove

Elze Stoop

Nicky Peeters

Vanessa van Tittelboom

Patricia Van de Walle

Marleen Van den Hauwe

Nathalie Goemans

Liesbeth De Waele

Anja Van Campenhout

Britta Hanssen

Kaat Desloovere

Affiliations

Soon will be listed here.

Abstract

The aim of this study was to determine the clinimetric properties, i.e., reliability, validity and responsiveness of an instrumented strength assessment in typically developing (TD) children and children with cerebral palsy (CP) and Duchenne muscular dystrophy (DMD). Force (N), torque (Nm) and normalized torque (Nm/kg) were defined for maximal voluntary isometric contractions (MVICs) of the lower limb muscles using a pre-established protocol. Intraclass correlation coefficient (ICC), standard error of measurement (SEM) and minimal detectable change (MDC) of TD children ( = 14), children with CP ( = 11) and DMD ( = 11) were used to evaluate intra-rater reliability for the three cohorts and the inter-rater intersession as well as inter-rater intrasession reliability for TD children. Construct validity was assessed by comparing MVICs in TD children ( = 28) to children with CP ( = 26) and to children with DMD ( = 30), using the Kruskal Wallis and post-hoc Mann-Whitney U tests. Responsiveness was investigated by assessing changes in MVICs following a strength intervention in CP ( = 26) and a 1 and 2 year follow-up study in DMD ( = 13 and = 6, respectively), using the Wilcoxon Signed-Rank test. The overall intra-rater reliability, was classified as good to excellent for 65.1%, moderate for 27.0% and poor for 7.9% of the measures (47.6%, 76.2%, and 66.7% good-excellent; 28.6%, 23.8%, and 33.7% moderate; 23.8%, 0%, and 0% poor in TD, CP, and DMD, respectively), while ICC values for TD children were slightly lower for inter-rater intrasession reliability (38.1% good-excellent, 33.3% moderate and 26.6% poor) and for inter-rater intersession reliability (47.6% good-excellent, 23.8% moderate and 28.6% poor). Children with CP and DMD were significantly weaker than TD children ( < 0.001) and the majority of these strength differences exceeded the MDC. Children with CP significantly improved strength after training, with changes that exceeded the SEMs, whereas only limited strength decreases over time were observed in the DMD cohort. In conclusion, the investigated instrumented strength assessment was sufficiently reliable to confirm known-group validity for both cohorts and could detect the responsiveness of children with CP after a strength intervention. However, more research is necessary to determine the responsiveness of this assessment in children with DMD regarding their natural decline.

Citing Articles

Progressive resistance training for children with cerebral palsy: A randomized controlled trial evaluating the effects on muscle strength and morphology.

Hanssen B, Peeters N, De Beukelaer N, Vannerom A, Peeters L, Molenaers G Front Physiol. 2022; 13:911162.

PMID: 36267577 PMC: 9577365. DOI: 10.3389/fphys.2022.911162.

References

Hoffman E, Fischbeck K, Brown R, Johnson M, Medori R, Loike J . Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med. 1988; 318(21):1363-8. DOI: 10.1056/NEJM198805263182104. View

. Surveillance of cerebral palsy in Europe: a collaboration of cerebral palsy surveys and registers. Surveillance of Cerebral Palsy in Europe (SCPE). Dev Med Child Neurol. 2000; 42(12):816-24. DOI: 10.1017/s0012162200001511. View

Dallmeijer A, Baker R, Dodd K, Taylor N . Association between isometric muscle strength and gait joint kinetics in adolescents and young adults with cerebral palsy. Gait Posture. 2010; 33(3):326-32. DOI: 10.1016/j.gaitpost.2010.10.092. View

Walter S, Eliasziw M, Donner A . Sample size and optimal designs for reliability studies. Stat Med. 1998; 17(1):101-10. DOI: 10.1002/(sici)1097-0258(19980115)17:1<101::aid-sim727>3.0.co;2-e. View

Ryan J, Cassidy E, Noorduyn S, OConnell N . Exercise interventions for cerebral palsy. Cochrane Database Syst Rev. 2017; 6:CD011660. PMC: 6481791. DOI: 10.1002/14651858.CD011660.pub2. View

Goudriaan M, Nieuwenhuys A, Schless S, Goemans N, Molenaers G, Desloovere K . A new strength assessment to evaluate the association between muscle weakness and gait pathology in children with cerebral palsy. PLoS One. 2018; 13(1):e0191097. PMC: 5764363. DOI: 10.1371/journal.pone.0191097. View

Dallmeijer A, Rameckers E, Houdijk H, Groot S, Scholtes V, Becher J . Isometric muscle strength and mobility capacity in children with cerebral palsy. Disabil Rehabil. 2015; 39(2):135-142. DOI: 10.3109/09638288.2015.1095950. View

Faigenbaum A, Kraemer W, Blimkie C, Jeffreys I, Micheli L, Nitka M . Youth resistance training: updated position statement paper from the national strength and conditioning association. J Strength Cond Res. 2009; 23(5 Suppl):S60-79. DOI: 10.1519/JSC.0b013e31819df407. View

Verschuren O, Ada L, Maltais D, Gorter J, Scianni A, Ketelaar M . Muscle strengthening in children and adolescents with spastic cerebral palsy: considerations for future resistance training protocols. Phys Ther. 2011; 91(7):1130-9. DOI: 10.2522/ptj.20100356. View

10.

Hanssen B, Peeters N, Vandekerckhove I, De Beukelaer N, Bar-On L, Molenaers G . The Contribution of Decreased Muscle Size to Muscle Weakness in Children With Spastic Cerebral Palsy. Front Neurol. 2021; 12:692582. PMC: 8350776. DOI: 10.3389/fneur.2021.692582. View

11.

Clark R, Locke M, Hill B, Wells C, Bialocerkowski A . Clinimetric properties of lower limb neurological impairment tests for children and young people with a neurological condition: A systematic review. PLoS One. 2017; 12(7):e0180031. PMC: 5495217. DOI: 10.1371/journal.pone.0180031. View

12.

Birnkrant D, Bushby K, Bann C, Apkon S, Blackwell A, Brumbaugh D . Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol. 2018; 17(3):251-267. PMC: 5869704. DOI: 10.1016/S1474-4422(18)30024-3. View

13.

Al Jumah M, Muhaizea M, Al Rumayyan A, Al Saman A, Al Shehri A, Cupler E . Current management of Duchenne muscular dystrophy in the Middle East: expert report. Neurodegener Dis Manag. 2019; 9(3):123-133. PMC: 6609894. DOI: 10.2217/nmt-2019-0002. View

14.

El Mhandi L, Bethoux F . Isokinetic testing in patients with neuromuscular diseases: a focused review. Am J Phys Med Rehabil. 2012; 92(2):163-78. DOI: 10.1097/PHM.0b013e31826ed94c. View

15.

Baschung Pfister P, de Bruin E, Sterkele I, Maurer B, de Bie R, Knols R . Manual muscle testing and hand-held dynamometry in people with inflammatory myopathy: An intra- and interrater reliability and validity study. PLoS One. 2018; 13(3):e0194531. PMC: 5875759. DOI: 10.1371/journal.pone.0194531. View

16.

Goudriaan M, Van den Hauwe M, Simon-Martinez C, Huenaerts C, Molenaers G, Goemans N . Gait deviations in Duchenne muscular dystrophy-Part 2. Statistical non-parametric mapping to analyze gait deviations in children with Duchenne muscular dystrophy. Gait Posture. 2018; 63:159-164. DOI: 10.1016/j.gaitpost.2018.04.038. View

17.

Scholtes V, Dallmeijer A, Rameckers E, Verschuren O, Tempelaars E, Hensen M . Lower limb strength training in children with cerebral palsy--a randomized controlled trial protocol for functional strength training based on progressive resistance exercise principles. BMC Pediatr. 2008; 8:41. PMC: 2579291. DOI: 10.1186/1471-2431-8-41. View

18.

Mockford M, Caulton J . The pathophysiological basis of weakness in children with cerebral palsy. Pediatr Phys Ther. 2010; 22(2):222-33. DOI: 10.1097/PEP.0b013e3181dbaf96. View

19.

Odding E, Roebroeck M, Stam H . The epidemiology of cerebral palsy: incidence, impairments and risk factors. Disabil Rehabil. 2006; 28(4):183-91. DOI: 10.1080/09638280500158422. View

20.

Fowler E, Staudt L, Greenberg M, Oppenheim W . Selective Control Assessment of the Lower Extremity (SCALE): development, validation, and interrater reliability of a clinical tool for patients with cerebral palsy. Dev Med Child Neurol. 2009; 51(8):607-14. DOI: 10.1111/j.1469-8749.2008.03186.x. View